TMS Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers: R-baclofen Effects in Normal Volunteers
Transcranial Magnetic Stimulation (TMS) Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers for R-baclofen Effects in Normal Volunteers
Sponsor: Boston Children's Hospital
Terminated
too much variability in the TMS measures
Other terminated trials from Boston Children's Hospital
A PHASE1 clinical study on Autism, this trial is terminated or withdrawn. The trial is conducted by Boston Children's Hospital and has accumulated 7 data snapshots since 2010. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Terminated PHASE1
-
Jun 2018 — Sep 2020 [monthly]
Terminated PHASE1
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Children's Hospital
- Gonzalez-Heydrich, Joseph, M.D.
- Seaside Therapeutics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .